Acer Therapeutics (ACER) and Relief Announce FDA Approval of OLPRUVA Dec 27, 2022 08:32AM
Acer Therapeutics and Relief Therapeutics Announce U.S. FDA Approval of OLPRUVAâ„¢ for Patients with Urea Cycle Disorders Dec 27, 2022 08:30AM
Acer Therapeutics Reports Q1 2022 Financial Results and Provides Corporate Update May 16, 2022 04:01PM
Acer Therapeutics Secures up to $48.5 Million in Convertible Note and Secured Loan Financing Facilities Mar 7, 2022 06:15AM